Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 1877

1.

BDNF Val66Met polymorphism is not related with temporal lobe epilepsy caused by hippocampal sclerosis in Brazilian population.

Alcantara JA, Vincentiis S, Santos B, Kerr D, de Paula V, Alessi R, Linden H, Chaim T, Serpa M, Busatto G, Gattaz W, Valente KD.

Seizure. 2018 Aug;60:159-162. doi: 10.1016/j.seizure.2018.07.004. Epub 2018 Jul 7.

PMID:
30015148
2.

Response of brain-derived neurotrophic factor to combining cognitive and physical exercise.

Miyamoto T, Hashimoto S, Yanamoto H, Ikawa M, Nakano Y, Sekiyama T, Kou K, Kashiwamura SI, Takeda C, Fujioka H.

Eur J Sport Sci. 2018 Sep;18(8):1119-1127. doi: 10.1080/17461391.2018.1470676. Epub 2018 May 29.

PMID:
29842831
3.

Childhood trauma interacted with BDNF Val66Met influence schizophrenic symptoms.

Bi XJ, Lv XM, Ai XY, Sun MM, Cui KY, Yang LM, Wang LN, Yin AH, Liu LF.

Medicine (Baltimore). 2018 Mar;97(13):e0160. doi: 10.1097/MD.0000000000010160.

4.

The relationship between BDNF Val66Met polymorphism and functional mobility in chronic stroke survivors.

French MA, Morton SM, Pohlig RT, Reisman DS.

Top Stroke Rehabil. 2018 May;25(4):276-280. doi: 10.1080/10749357.2018.1437938. Epub 2018 Feb 25.

PMID:
29480080
5.

Meta-Analysis on the Association between Brain-Derived Neurotrophic Factor Polymorphism rs6265 and Ischemic Stroke, Poststroke Depression.

Bao MH, Zhu SZ, Gao XZ, Sun HS, Feng ZP.

J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1599-1608. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.010. Epub 2018 Feb 13. Review.

PMID:
29449128
6.

Association Analysis of the Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Gender with Efficacy of Antidepressants in the Chinese Han Population with Generalized Anxiety Disorder.

Lin M, Zhu J, Yuan Y, Ren L, Qian M, Shen Z, Shao Y, Shen X.

Genet Test Mol Biomarkers. 2018 Mar;22(3):199-206. doi: 10.1089/gtmb.2017.0053. Epub 2018 Feb 15.

PMID:
29446659
7.

Pharmacogenetics of Risperidone-Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder.

Sukasem C, Vanwong N, Srisawasdi P, Ngamsamut N, Nuntamool N, Hongkaew Y, Puangpetch A, Chamkrachangpada B, Limsila P.

Basic Clin Pharmacol Toxicol. 2018 Jul;123(1):42-50. doi: 10.1111/bcpt.12970. Epub 2018 Mar 30.

PMID:
29369497
8.

Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson's disease or essential tremor.

Huang Y, Yun W, Zhang M, Luo W, Zhou X.

J Int Med Res. 2018 Apr;46(4):1477-1485. doi: 10.1177/0300060517748843. Epub 2018 Jan 19.

9.

Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.

Skibinska M, Groszewska A, Kapelski P, Rajewska-Rager A, Pawlak J, Dmitrzak-Weglarz M, Szczepankiewicz A, Twarowska-Hauser J.

Pharmacol Rep. 2018 Feb;70(1):55-59. doi: 10.1016/j.pharep.2017.08.002. Epub 2017 Aug 12.

PMID:
29331787
10.

Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia.

Bakirhan A, Yalcin Sahiner S, Sahiner IV, Safak Y, Goka E.

PLoS One. 2017 Dec 29;12(12):e0189373. doi: 10.1371/journal.pone.0189373. eCollection 2017.

11.

Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.

Ng T, Lee YY, Chae JW, Yeo AHL, Shwe M, Gan YX, Ng RCH, Chu PPY, Khor CC, Ho HK, Chan A.

BMC Cancer. 2017 Dec 19;17(1):867. doi: 10.1186/s12885-017-3861-9.

12.

Pathobiological expression of the brain-derived neurotrophic factor (BDNF) in cerebellar cortex of sudden fetal and infant death victims.

Lavezzi AM, Ferrero S, Lattuada D, Piscioli F, Alfonsi G, Matturri L.

Int J Dev Neurosci. 2018 May;66:9-17. doi: 10.1016/j.ijdevneu.2017.11.003. Epub 2017 Nov 23.

PMID:
29174061
13.

Peripheral brain-derived neurotrophic factor in attention-deficit/hyperactivity disorder: A comprehensive systematic review and meta-analysis.

Zhang J, Luo W, Li Q, Xu R, Wang Q, Huang Q.

J Affect Disord. 2018 Feb;227:298-304. doi: 10.1016/j.jad.2017.11.012. Epub 2017 Nov 6. Review.

PMID:
29132072
14.

Decreased Serum Brain-Derived Neurotrophic Factor May Indicate the Development of Poststroke Depression in Patients with Acute Ischemic Stroke: A Meta-Analysis.

Xu HB, Xu YH, He Y, Xue F, Wei J, Zhang H, Wu J.

J Stroke Cerebrovasc Dis. 2018 Mar;27(3):709-715. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.003. Epub 2017 Nov 8. Review.

PMID:
29128330
15.

BDNF Val66Met polymorphism, life stress and depression: A meta-analysis of gene-environment interaction.

Zhao M, Chen L, Yang J, Han D, Fang D, Qiu X, Yang X, Qiao Z, Ma J, Wang L, Jiang S, Song X, Zhou J, Zhang J, Chen M, Qi D, Yang Y, Pan H.

J Affect Disord. 2018 Feb;227:226-235. doi: 10.1016/j.jad.2017.10.024. Epub 2017 Oct 16. Review.

PMID:
29102837
16.

Actions of Brain-Derived Neurotrophic Factor and Glucocorticoid Stress in Neurogenesis.

Numakawa T, Odaka H, Adachi N.

Int J Mol Sci. 2017 Nov 2;18(11). pii: E2312. doi: 10.3390/ijms18112312. Review.

17.

The association between serum brain-derived neurotrophic factor and a cluster of cardiovascular risk factors in adolescents: The CHAMPS-study DK.

Pedersen NH, Tarp J, Andersen LB, Gejl AK, Huang T, Peijs L, Bugge A.

PLoS One. 2017 Oct 13;12(10):e0186384. doi: 10.1371/journal.pone.0186384. eCollection 2017.

18.

Do serum BDNF levels vary in self-harm behavior among adolescents and are they correlated with traumatic experiences?

Kavurma C, Varol Tas F, Serim Demirgoren B, Demirci F, Akan P, Eyuboglu D, Guvenir T.

Psychiatry Res. 2017 Dec;258:130-135. doi: 10.1016/j.psychres.2017.09.069. Epub 2017 Sep 28.

PMID:
29017139
19.

BDNF Val66Met polymorphism modulates the effect of loneliness on white matter microstructure in young adults.

Meng J, Hao L, Wei D, Sun J, Li Y, Qiu J.

Biol Psychol. 2017 Dec;130:41-49. doi: 10.1016/j.biopsycho.2017.10.002. Epub 2017 Oct 5.

PMID:
28988974
20.

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study.

Schosser A, Carlberg L, Calati R, Serretti A, Massat I, Spindelegger C, Linotte S, Mendlewicz J, Souery D, Zohar J, Montgomery S, Kasper S.

Int J Neuropsychopharmacol. 2017 Oct 1;20(10):782-787. doi: 10.1093/ijnp/pyx028.

Supplemental Content

Support Center